Christian Laurer
Senior Investment Manager @ tecnet equity
Sankt Pölten, Austria
Christian Laurer is a seed investor at tecnet equity in Sankt Pölten focused on Biotechnology and Health Care. As senior investment manager, Christian Laurer primarily serves companies in the field of life sciences. These include, for example, medical technology, diagnostics, digital health or environmental engineering. Companies with a protectable technology serving an unmet (medical) need are at the core of tecnet. In addition to his financing andresearch expertise, Dr Laurer has operational experience in marketing, sales and market research, which he honed during seven years of work in the diagnostic and pharmaceutical industries. Christian Laurer studied biology at the University of Vienna and wrote his PhD at the Austrian Institute of Technology while also holding a research fellowship at Unilever Research (UK). He is also a master car mechanic.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 55%
Last updated:
For AI agents: llms.txt
Industries Christian Laurer invests in
Stages Christian Laurer invests in
Countries Christian Laurer invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 4 (36%)
- Health Care 3 (27%)
- Software 2 (18%)
- Medical 1 (9%)
- Robotics 1 (9%)
Stage
- Seed 4 (36%)
- Series A 3 (27%)
- Funding Round 3 (27%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $19.7M / Series A / Jan 31, 2022 | ||
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $20.2M / Series A / Jan 31, 2022 | ||
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | Seed / Mar 08, 2019 | ||
| Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | Seed / Mar 08, 2019 | ||
| FOEX GmbH specializes in creating plugins and addon components for Oracle APEX. We provide a comprehensive Rapid Application Development (RAD) framework for the enterprise, meticulously engineered and crafted for people to transform ideas into working business applications. The FOEX Plugin Framework offers a fast and easy way to create, deploy,change and manage data-heavy web applications, using a set of powerful plugins and high performance UI components. | $219K / Dec 28, 2016 | ||
| Jeder is a dental technology development company that specializes in sinus lift. The healthcare company develops a sinus lift system called Jeder System. It is a surgery that adds bone to humans' upper jaw in the back area of the teeth (molars and premolars). | Aug 08, 2016 | ||
| FOEX GmbH specializes in creating plugins and addon components for Oracle APEX. We provide a comprehensive Rapid Application Development (RAD) framework for the enterprise, meticulously engineered and crafted for people to transform ideas into working business applications. The FOEX Plugin Framework offers a fast and easy way to create, deploy,change and manage data-heavy web applications, using a set of powerful plugins and high performance UI components. | $549K / Seed / May 06, 2015 | ||
| Jeder is a dental technology development company that specializes in sinus lift. The healthcare company develops a sinus lift system called Jeder System. It is a surgery that adds bone to humans' upper jaw in the back area of the teeth (molars and premolars). | Jun 14, 2013 | ||
| Sealife is a leading marine biopharma company pioneering the discovery and development of novel biochemistry isolated from the under-explored biological diversity of marine fungi.Their core focus is to develop novel antibiotics to treat multi-drug resistant Gram negative and Gram positive infections e.g. Pseudomonas aeruginosa, Acinetobacterbaumanii, Penicillin resistant Streptococci pneumoniae (PRSP), MRSA and Vancomycin resistant enterococci (VRE).In addition, Sealife has discovery and development activities in the development of antimicrobials and disinfection agents. | Seed / Mar 04, 2011 | ||
| Anagnostics specializes in developing systems and tests for research and clinical in-vitro-diagnostics. Their goal is to provide solutions for unmet needs especially in protein and infectious disease diagnostics | $4.1M / Feb 27, 2009 | ||
| See all 11 investments → | |||
Co-Investors
About tecnet equity
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
tecnet equity Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christian Laurer
Senior Investment Manager
|
|||
Doris Agneter
Managing Director
|
|||
Juergen Milde-Ennoeckl
Investment Manager
|
|||
Peter Buchinger
Investment Analyst
|
|||
René Danzinger
Investment Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Christian Laurer invest in?
Christian Laurer invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christian Laurer?
Public channels for Christian Laurer include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christian Laurer last invest?
The most recent investment recorded for Christian Laurer closed in Jan 2022. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
